Accelerate Diagnostics, Inc. (AXDX)

Accelerate Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14.61	12.14	34.91	39.9	35.78	61.01
Short-Term Investments	1.15	1.08	10.66	23.72	32.49	47.44
Cash & Cash Equivalents	15.75	13.22	45.56	63.62	68.27	108.45
Cash Growth	-50.57%	-70.99%	-28.38%	-6.81%	-37.05%	-34.86%
Receivables	2.22	2.62	2.42	2.32	1.55	3.22
Inventory	3.25	3.31	5.19	5.07	9.22	8.06
Other Current Assets	2.92	5.32	2.84	2.33	2.95	2.12
Total Current Assets	24.13	24.47	56.01	73.33	81.99	121.85
Property, Plant & Equipment	5.38	5.08	7.76	7.9	9.32	11.82
Other Long-Term Assets	1.21	1.82	1.24	1.82	2.12	0.75
Total Long-Term Assets	6.59	6.9	9	9.72	11.44	12.57
Total Assets	30.72	31.37	65.02	83.05	93.43	134.42
Accounts Payable	5.11	4.8	4.5	1.98	1.29	2.35
Deferred Revenue	2.38	2.67	0.55	0.45	0.38	0.27
Current Debt	2.35	2.29	58.36	0.75	1.05	0.45
Other Current Liabilities	6.29	2.29	3.15	3.76	4.25	5.09
Total Current Liabilities	16.13	12.03	66.56	6.95	6.97	8.16
Long-Term Debt	38.06	36.93	19.19	110.37	148.93	133.62
Other Long-Term Liabilities	2.31	2.29	1.54	0.81	0.34	0.02
Total Long-Term Liabilities	40.37	39.22	20.72	111.17	149.27	133.64
Total Liabilities	56.5	51.25	87.28	118.12	156.24	141.8
Total Debt	40.42	39.22	77.54	111.11	149.98	134.07
Debt Growth	-48.21%	-49.42%	-30.22%	-25.92%	11.87%	11.66%
Retained Earnings	-683.09	-668.86	-607.24	-570.67	-492.97	-414.65
Comprehensive Income	-0.62	-0.61	-0.4	-0.06	0.09	-0.06
Shareholders' Equity	-25.78	-19.89	-22.26	-35.07	-62.81	-7.38
Net Cash / Debt	-24.66	-26	-31.98	-47.5	-81.71	-25.62
Net Cash Per Share	-1.28	-2.08	-3.89	-7.69	-14.59	-4.70
Working Capital	8	12.43	-10.54	66.39	75.02	113.69
Book Value Per Share	-1.34	-1.59	-2.71	-5.68	-11.21	-1.35

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).